Mamas Mamas
Latest contributions
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
STEMI: how to treat the thrombus
18 May 2023 – From EuroPCR 2023
Consult this session to gain insights into the treatment of thrombus in STEMI cases: discover a primary angioplasty trick for managing a thrombus-laden RCA, explore the effectiveness of intracoronary thrombolysis and aspiration thrombectomy, uncover a unique approach to addressing left main stem complications with a "less...
What to do with isolated non left main side branch stenosis?
17 May 2023 – From EuroPCR 2023
Encountered isolated non left main side branch stenosis? Unsure how to proceed? Join this session to discuss treatment dilemmas for symptomatic patients with positive stress tests. Explore risks to the main vessel and learn safe approaches. Don't miss out!
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
Clinical and economic burden of reduced PCI access during UK COVID-19 lockdown – A We CARE analysis
18 May 2022 – From EuroPCR 2022
Across Europe, during the COVID pandemic, there was a big reduction in patients presenting for primary PCI. Interviewed by Nicola Ryan, Mamas Mamas summarises the key points from the We CARE study which analysed the effect at the population level in terms of heart failure diagnosis, cost...
Primary PCI: new issues, new solutions
19 May 2022 – From EuroPCR 2022
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stents:
- First machine learning derived risk score for target lesion failure
- Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
- Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
- 2-year outcomes of the randomized SORT OUT IX Trial
- Outcomes of...
The power of BIG DATA for PCI in practice
Watch this session if you want to understand the value of BIG DATA from global registries in interventional cardiology, to explore regional differences in percutaneous coronary interventions and potential impact on clinical outcomes and to learn how large registry data can impact your practice.
Speakers: Marco Roffi,...
Hotlines and innovations on left main & multivessel disease - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of left main & multivessel disease:
- One-year clinical outcomes of complex PCI treated with use of Ultimaster stent
- Impact of residual SYNTAX score on all-cause death at 10 yrs in the SYNTAX trial
